CYAD logo

Celyad Oncology SA (CYAD) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$13.35 M
-$20.64 M-60.73%

December 31, 2022


Summary


Performance

CYAD Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCYADbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$15.03 M
-$7.87 M-34.37%

June 30, 2022


Summary


Performance

CYAD Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCYADbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

CYAD Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-60.7%+5.1%
3 y3 years-69.7%-60.8%
5 y5 years-52.2%-44.0%

CYAD Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-60.7%at low-55.8%at low
5 y5-year-69.7%at low-65.9%-52.9%
alltimeall time-87.8%-83.7%-88.5%-85.5%

Celyad Oncology SA Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2022
$13.35 M(-60.7%)
-
Jun 2022
-
$15.03 M(-34.4%)
Mar 2022
-
$22.89 M(-32.6%)
Dec 2021
$33.99 M(+60.3%)
$33.99 M(+380.5%)
Sep 2021
-
$7.07 M(-50.5%)
Jun 2021
-
$14.30 M(+0.5%)
Mar 2021
-
$14.22 M(-32.9%)
Dec 2020
$21.20 M(-51.9%)
$21.20 M(-29.4%)
Jun 2020
-
$30.02 M(-31.9%)
Dec 2019
$44.07 M(-5.0%)
$44.07 M(+15.1%)
Jun 2019
-
$38.28 M(-17.5%)
Dec 2018
$46.38 M
$46.38 M(-35.7%)
DateAnnualQuarterly
Jun 2018
-
$72.13 M(+158.6%)
Dec 2017
$27.90 M(-45.4%)
$27.90 M(+4.0%)
Jun 2017
-
$26.82 M(-47.5%)
Dec 2016
$51.12 M(-53.3%)
$51.12 M(-14.4%)
Jun 2016
-
$59.72 M(-45.5%)
Dec 2015
$109.52 M(+225.9%)
$109.52 M(-15.9%)
Jun 2015
-
$130.24 M(+287.6%)
Dec 2014
$33.60 M(+27.7%)
$33.60 M(-29.8%)
Jun 2014
-
$47.85 M(+81.8%)
Dec 2013
$26.32 M(+1109.6%)
$26.32 M(+412.1%)
Jun 2013
-
$5.14 M(+136.2%)
Dec 2012
$2.18 M
$2.18 M

FAQ

  • What is Celyad Oncology SA annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Celyad Oncology SA?
  • What is Celyad Oncology SA annual cash & cash equivalents year-on-year change?
  • What is Celyad Oncology SA quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Celyad Oncology SA?
  • What is Celyad Oncology SA quarterly cash and cash equivalents year-on-year change?

What is Celyad Oncology SA annual cash & cash equivalents?

The current annual cash & cash equivalents of CYAD is $13.35 M

What is the all time high annual cash & cash equivalents for Celyad Oncology SA?

Celyad Oncology SA all-time high annual cash & cash equivalents is $109.52 M

What is Celyad Oncology SA annual cash & cash equivalents year-on-year change?

Over the past year, CYAD annual cash & cash equivalents has changed by -$20.64 M (-60.73%)

What is Celyad Oncology SA quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of CYAD is $15.03 M

What is the all time high quarterly cash and cash equivalents for Celyad Oncology SA?

Celyad Oncology SA all-time high quarterly cash and cash equivalents is $130.24 M

What is Celyad Oncology SA quarterly cash and cash equivalents year-on-year change?

Over the past year, CYAD quarterly cash and cash equivalents has changed by +$725.80 K (+5.08%)